Luxonus Inc.
Bringing innovation to the medical world with photoacoustic imaging technology that fuses light and ultrasound
Luxonus' photoacoustic 3D imaging can depict internal tissue in a non-invasive way with ultra-high-resolution 3D images. Clinical research has shown that it contributes to diagnosing and treating diseases such as vascular disease, breast cancer, and lymphedema, which conventional technologies have struggled to diagnose early and determine the efficacy of treatment.
- Establishment Date
- December 2018
- Business
- Development and sales of imaging equipment using photoacoustic technology
- CEO
- Sadakazu Aiso, President and CEO
KII’s Perspective
We expect that product development based on the fundamental technology and basic research that we have cultivated to date will establish our technology as the “fifth modality” following ultrasound, CT, MRI, and SPECT/PET.
KII growth support
Financing assistance, Business alliance support, Sales strategy planning support, Recruitment support, Public relations support, Appointment of directors
